ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

“Deadly Vision” Receives the Literary Titan Gold Book Award, Cementing Its Status as a Top Medical Techno Thriller

By: Get News
"Deadly Vision" Receives the Literary Titan Gold Book Award, Cementing Its Status as a Top Medical Techno Thriller

Deadly Vision, the acclaimed medical and techno thriller by T. D. Severin, has been awarded the prestigious Literary Titan Gold Book Award, further solidifying its reputation as one of the most compelling and thought-provoking thrillers of the year. This honor follows its recognition as the Winner of the AMERICAN FICTION AWARD 2025, celebrating literary excellence and innovative storytelling.

Praised by New York Times bestselling author Robert Dugoni as “a gripping novel of suspense ingeniously plotted,” Deadly Vision takes readers deep into the cutting edge of medical virtual reality, where innovation collides with political ambition, corporate sabotage, and life-or-death stakes. Dugoni notes that “Dr. Severin writes with an expert's hand in virtual reality and medicine, creating a unique, intriguing and intelligent medical and techno thriller that blew me away from its opening page.”

The Literary Titan review calls Deadly Vision “ambitious and messy and alive,” a novel that begins as a high-tech thriller and escalates into a chilling examination of power, morality, and the cost of progress. Reviewer praise highlights its relentless pace, cinematic style, and vivid medical realism. “At its heart,” the review states, “it asks one big question: how far would we go in the name of progress.”

The story follows Dr. Taylor Abrahms, a brilliant yet battle-worn ER physician whose revolutionary research in Medical Virtual Reality threatens entrenched interests inside the volatile political landscape of San Francisco University Medical Center. With health care reform igniting national conflict and a presidential election hanging in the balance, Taylor is thrust into a deadly struggle. His career is destroyed, his research sabotaged, and his colleagues are murdered as powerful forces race to stop the Virtual Heart Project at any cost. Isolated, hunted, and fighting for someone he loves, Taylor confronts a conspiracy that blurs the line between medical miracle and political weapon.

With its blend of scientific authenticity, gripping suspense, and emotional depth, Deadly Vision continues to resonate with readers who crave thrillers that challenge the mind as much as they accelerate the pulse.

Deadly Vision is now available in print and digital formats on Amazon and Barnes & Noble, and available as an audiobook. Readers seeking an intelligent, high-stakes medical and political thriller are encouraged to pick up their copy today.

James Boschert, author of the Talon Series, writes that Severin “takes the reader by the scruff of their emotions and gives them a darned good shake,” calling Deadly Vision “a thriller in the top tier of that genre.”

Listen to the Audiobook for Free Today

Experience the intensity of Deadly Vision in a whole new way. The audiobook is now available to listen to for free on Amazon. Click here to dive into the suspense, the high-stakes medical drama, and the gripping political intrigue brought to life through powerful narration.

Media Contact
Company Name: Literary Titan
Contact Person: Todd Severin
Email: Send Email
Country: United States
Website: https://amzn.to/3LGyMPt

Recent Quotes

View More
Symbol Price Change (%)
AMZN  233.22
+4.06 (1.77%)
AAPL  278.85
+1.30 (0.47%)
AMD  217.53
+3.29 (1.54%)
BAC  53.65
+0.66 (1.25%)
GOOG  320.12
-0.16 (-0.05%)
META  647.95
+14.34 (2.26%)
MSFT  492.01
+6.51 (1.34%)
NVDA  177.00
-3.26 (-1.81%)
ORCL  201.95
-3.01 (-1.47%)
TSLA  430.17
+3.59 (0.84%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.